Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

Aim. To evaluate the clinical experience of bosutinib use for treatment of chronic myeloid leukemia (CML) patients with intolerance and resistance to other tyrosine kinase inhibitors (TKI), as well as to compare the obtained results with the data of clinical trials. Materials & Methods. The analy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	V. A. Shuvaev, Ol’ga Yur’evna Vinogradova, I. S. Martynkevich, N. V. Novitskaya, M. S. Fominykh, S. N. Tsareva, D. I. Shikhbabaeva, M. M. Pankrashkina, M. V. Chernikov, N. N. Sharkunov, I. I. Zotova, V. Yu. Udal’eva, E. V. Motyko, S. V. Voloshin
Formato:	Artigo
Idioma:	Russo
Publicado em:	Practical Medicine Publishing House 2018-10-01
coleção:	Клиническая онкогематология
Assuntos:	chronic myeloid leukemia bosutinib target therapy tyrosine kinase inhibitors clinical practice
Acesso em linha:	https://bloodjournal.ru/index.php/coh/article/view/377
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!